rs121909071
|
SLC22A18
|
Carcinoma of lung
|
|
0.800 |
GeneticVariation |
UNIPROT |
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.
|
25311215 |
2014 |
rs121909071
|
SLC22A18
|
Carcinoma of lung
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.
|
24627688 |
2014 |
rs121909071
|
SLC22A18
|
Carcinoma of lung
|
|
0.800 |
GeneticVariation |
UNIPROT |
Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.
|
24846033 |
2014 |
rs121909071
|
SLC22A18
|
Carcinoma of lung
|
|
0.800 |
GeneticVariation |
UNIPROT |
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
|
23562183 |
2013 |
rs121909071
|
SLC22A18
|
Carcinoma of lung
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group.
|
23667368 |
2013 |
rs16928809
|
SLC22A18
|
Bilirubin measurement
|
A |
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association meta-analysis for total serum bilirubin levels.
|
19414484 |
2009 |
rs16928809
|
SLC22A18
|
Bilirubin measurement
|
A |
0.800 |
GeneticVariation |
GWASDB |
Genome-wide association meta-analysis for total serum bilirubin levels.
|
19414484 |
2009 |
rs121909071
|
SLC22A18
|
Carcinoma of lung
|
T |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs1661052
|
SLC22A18
|
Bilirubin measurement
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
rs16928809
|
SLC22A18
|
High density lipoprotein measurement
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Exome-wide association study of plasma lipids in >300,000 individuals.
|
29083408 |
2017 |
rs16928809
|
SLC22A18
|
Bilirubin level result
|
A |
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association meta-analysis for total serum bilirubin levels.
|
19414484 |
2009 |
rs78838117
|
SLC22A18
|
RHABDOMYOSARCOMA, SOMATIC
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs749280481
|
SLC22A18
|
Neoplasms
|
|
0.010 |
GeneticVariation |
BEFREE |
The G1120A substitution thus represents either a rare polymorphism or a tumor-predisposing mutation, because the mutant allele was of maternal origin and preferentially expressed in the patient's tissue.
|
9751628 |
1998 |
rs749280481
|
SLC22A18
|
Nephroblastoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Mutational analysis of TSSC5 by direct DNA sequencing of exons revealed a base substitution of G1120A in a Wilms' tumor, matched normal kidney, and the patient's mother, changed Arg at codon 309 to Gln.
|
9751628 |
1998 |
rs749280481
|
SLC22A18
|
Childhood Kidney Wilms Tumor
|
|
0.010 |
GeneticVariation |
BEFREE |
Mutational analysis of TSSC5 by direct DNA sequencing of exons revealed a base substitution of G1120A in a Wilms' tumor, matched normal kidney, and the patient's mother, changed Arg at codon 309 to Gln.
|
9751628 |
1998 |